Twist Bioscience officer proposes $170K share sale
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Twist Bioscience Corp (TWST) officer Robert F. Werner filed notice of a proposed sale of 1,637 common shares, with an aggregate market value of $169,737.91 and an approximate sale date of November 16, 2026. The shares were acquired through restricted stock vesting on November 12, 2026, as compensation; the notice says the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award distribution. It lists prior sales of 669 shares on August 21, 854 on August 24, 238 on September 8, 1,482 on October 2 and 148 on November 3, 2026.
Key Figures
Key Terms
Restricted Stock Vesting financial
Aggregate Market Value financial
vested equity award distribution financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.